to expand on the findings from previous clinical trials that the growth of residual tumor is increased at a predictable time following initial drug administration , malignant plasma cells from bone marrows of patients with multiple myeloma ( mm ) were examined for changes in proliferation and clonogenicity induced in vivo by cyclophosphamide and in vitro by drug-induced humoral stimulatory activity .
C0026764
multiple myeloma
C0010583
cyclophosphamide